Life Sciences Quarterly
A View From Washington: What to Expect From the SEC
Please join the chair of Ropes & Gray’s securities and governance practice, Keith Higgins, and Ropes & Gray partners Pat O’Brien and Chris Comeau as they review the status of new and existing initiatives by Congress and the SEC. Keith recently rejoined the firm after serving for more than three years as the director of corporation finance at the SEC, and will offer unique insights into these rules, filings and initiatives. This session will provide the audience with an in-depth sense of what to expect from Washington and how it will affect disclosure, governance and capital formation. The topics covered will include:
- CEO pay ratio disclosure, which is required in next year’s proxy statement
- The Financial CHOICE Act and the repeal and replacement of Dodd-Frank
- New faces at the SEC—with Congress otherwise occupied, will the Commission be able to set its own agenda?
- Why are there fewer IPOs, and what can the SEC do about it?
- Practical tips on interactions with SEC Staff and resolving SEC comments
- Developments in private financings, including Regulation A
- Prospects for changes to shareholder proposals and proxy advisory firms
- Status of disclosure effectiveness
Life Sciences Quarterly is a quarterly seminar series developed for Ropes & Gray’s life sciences clients. We will bring you the insights of Ropes & Gray attorneys, speakers from government and industry, and other professionals as they examine key developments, issues and trends affecting the life sciences industry. Please watch for invitations quarterly. If you were unable to attend our previous Life Sciences Quarterly seminars, you can access the recordings and transcripts here.